DNA X, Inc. (SONM)
NASDAQ: SONM · Real-Time Price · USD
5.12
-0.19 (-3.58%)
Mar 4, 2026, 3:04 PM EST - Market open

DNA X Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
118.5109.22187.2669.8354.5763.99
Revenue Growth (YoY)
11.97%-41.68%168.18%27.96%-14.72%-44.95%
Cost of Revenue
48.2848.3874.3158.2148.1648.78
Gross Profit
10.839.9219.3211.626.4115.21
Selling, General & Admin
27.0125.3517.0417.9419.8520.25
Research & Development
15.2314.241.777.9717.716.22
Other Operating Expenses
0.253.98--6.878.01
Total Operating Expenses
42.4943.5618.8125.9144.4244.47
Operating Income
-32.17-33.640.51-14.29-38-29.26
Interest Expense
-1.01-0.03-0.02-0.1--0.76
Other Non-Operating Income (Expense)
-0.340.25-0.210.48-0.46-0.43
Total Non-Operating Income (Expense)
-1.350.22-0.230.39-0.46-1.19
Pretax Income
-33.08-33.420.28-13.9-38.46-30.45
Provision for Income Taxes
-0.31-0.23-0.37-0.18-0.170.52
Net Income
-33.38-33.65-0.09-14.09-38.63-29.93
Net Income to Common
-33.38-33.65-0.09-14.09-38.63-29.93
Shares Outstanding (Basic)
100000
Shares Outstanding (Diluted)
100000
Shares Change (YoY)
111.07%10.04%48.42%2952.35%104.82%2383.85%
EPS (Basic)
-99.45-128.34-0.36-88.20-7344.00-11664.00
EPS (Diluted)
-99.45-128.34-0.36-88.20-7344.00-11664.00
Free Cash Flow
-26.04-8.7-4.09-12.37-38.52-10.57
Free Cash Flow Per Share
-49.33-33.19-17.16-77.06-7326.24-4117.81
Gross Margin
9.14%9.08%10.32%16.65%11.75%23.77%
Operating Margin
-27.15%-30.80%0.27%-20.46%-69.64%-45.72%
Profit Margin
-28.17%-30.81%-0.05%-20.17%-70.78%-46.77%
FCF Margin
-21.97%-7.97%-2.18%-17.71%-70.59%-16.52%
EBITDA
-28.45-30.082.72-11.92-35.87-26.53
EBITDA Margin
-24.01%-27.54%1.45%-17.06%-65.74%-41.46%
EBIT
-32.17-33.640.51-14.29-38-29.26
EBIT Margin
-27.15%-30.80%0.27%-20.46%-69.64%-45.72%
Effective Tax Rate
0.93%0.68%-131.69%1.32%0.43%-1.71%
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q